EX-99.2 3 form13g_exhibit992.htm EX-99.2

Document

Exhibit 99.2

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock of Ovid Therapeutics Inc. and further agree to the filing of this agreement as an Exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G.

Dated: December 9, 2025

TAKEDA PHARMACEUTICAL COMPANY LIMITED

                                                                                       By: /s/ Max Heuer

                                                                                       Name: Max Heuer

                                                                                       Title: Authorized Signatory

                                                                                TAKEDA PHARMACEUTICALS U.S.A., INC.

By: /s/ Paul Sundberg

                                                                                          Name: Paul Sundberg

                                                                                          Title: Assistant Secretary